PEStore

Accelerator/Incubator

Downing Capital Group

Downing Capital Group backs very early companies, usually with a programme attached, from United States. It states a focus on healthcare & life sciences, consumer & retail and software & internet.

Capital raised$77macross 1 SEC-filed vehicle
Most recent fund2021
HeadquartersUnited States
Largest single fund$77m

SEC filings

What Downing Capital Group has raised

From this firm's own Form D filings. A fund files one within fifteen days of its first sale, under penalty of perjury, which makes these the hardest numbers on the page.

Vehicles filed1
Total capital raised$77m
Largest single vehicle$77m
Filing history2021
Smallest accepted commitmentNone stated
Filed fromMASSACHUSETTS

Form D covers US-domiciled vehicles raised from accredited investors. It will not capture a fund raised outside the United States, separately managed accounts, or capital deployed off balance sheet, so treat these as a floor rather than a total.

Regulatory record

How Downing Capital Group is registered

From this firm's Form ADV, the annual filing every registered and exempt investment adviser makes to the SEC.

Adviser statusExempt reporting adviser
Regulatory assets under managementNot reported by an ERA
Private funds advised1 · $77m gross
SEC adviser numberCRD 318093

An exempt reporting adviser is not required to report regulatory assets under management, so the blank above means the question was not asked rather than that the answer is unknown. Where a figure exists it is the gross asset value of the private funds the firm advises, which is a different and usually larger measure.

Portfolio

Disclosed holdings

Companies Downing Capital Group lists on its own website. No investment years are published.

CompanyInvestedYears heldRecorded transaction
ADAS Calibration
Bloomwellcare
Calibright
Cedar Brands
Equilibrium
Equitable
Fertilicare
Immersivhealth
Ripple
Wellnestfertility
● For CEOs

Compiled from Downing Capital Group’s published portfolio page. Where a recorded transaction is shown, that company was the target of a reported deal and has most likely already been realised. Nothing here is represented as being for sale.

Valuation context

Transaction values in Healthcare & Life Sciences

What companies have actually sold for in healthcare & life sciences, across 1,263 recorded transactions.

Median consideration$110m
Middle 50%$30m-$318m
Revenue multiple2.8×
EBITDA multiple12.5×

The full healthcare & life sciences picture - most active acquirers, recent transactions and every investor in the sector.

For owners

Own a healthcare & life sciences business?

The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.

Request a confidential valuation

For investors

Is this Downing Capital Group?

Claim this profile to correct anything wrong and tell us what you are looking for. We will send matching opportunities as they arise.

Claim or correct this profile

Targeted buyer search

Which hundred of these would actually buy your business?

A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.

See how it works

Comparable investors

Similar mandates

Other accelerator/incubator investors active in healthcare & life sciences.